Iridex (IRIX) Change in Accured Expenses (2011 - 2026)
Iridex's (IRIX) quarterly Change in Accured Expenses came in at -$622000.0 in Q2 2026, down 226.42% year-on-year from $492000.0 in Q2 2025, and down 409.45% quarter-over-quarter from $201000.0 in Q1 2026.
Iridex (IRIX) Change in Accured Expenses (2011 - 2026) Analysis & Trends
Iridex's Change in Accured Expenses history runs 16 years deep, the most recent figure standing at -$622000.0 for Q2 2026.
- On a quarterly basis, Change in Accured Expenses fell 226.42% year-over-year to -$622000.0 in Q2 2026; TTM through Apr 2026 was -$577000.0, a 198.63% decrease from a year earlier, with the FY2026 full-year figure at $537000.0, down 26.44% from the prior year.
- Change in Accured Expenses retreated to -$622000.0 in Q2 2026 per IRIX's latest filing, from $201000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $1.4 million in Q3 2024 and bottomed at -$1.8 million in Q2 2024.
- The 5-year median for Change in Accured Expenses is $124000.0 (2023), against an average of $30277.8.
- Biggest YoY gain for Change in Accured Expenses was 1337.23% in 2024; the steepest drop was 309.51% in 2024.
- Year by year, Change in Accured Expenses stood at -$489000.0 in 2022, then jumped by 120.65% to $101000.0 in 2023, then soared by 401.98% to $507000.0 in 2024, then tumbled by 71.01% to $147000.0 in 2025, then slumped by 523.13% to -$622000.0 in 2026.
- Per Business Quant, the three latest IRIX Change in Accured Expenses figures stand at -$622000.0 (Q2 2026), $201000.0 (Q1 2026), and $147000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Iridex | 15.93 Mn | 11.33 Mn | 4.74 Mn | -622,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | -622,000.00 |
| Apr 4, 2026 | -622,000.00 |
| Jan 3, 2026 | 201,000.00 |
| Jan 3, 2026 | 201,000.00 |
| Sep 27, 2025 | 147,000.00 |
| Sep 27, 2025 | 147,000.00 |
| Jun 28, 2025 | -303,000.00 |
| Jun 28, 2025 | -303,000.00 |
| Mar 29, 2025 | 492,000.00 |
| Mar 29, 2025 | 492,000.00 |
| Dec 28, 2024 | 507,000.00 |
| Dec 28, 2024 | 507,000.00 |
| Sep 28, 2024 | 1.35 Mn |
| Sep 28, 2024 | 1.35 Mn |
| Jun 29, 2024 | -1.77 Mn |
| Jun 29, 2024 | -1.77 Mn |
| Mar 30, 2024 | 637,000.00 |
| Mar 30, 2024 | 637,000.00 |
| Dec 30, 2023 | 101,000.00 |
| Dec 30, 2023 | 101,000.00 |